Different subtypes of carcinoma in situ of the bladder do not have a different prognosis
| Autor: | Emmanuel Chartier-Kastler, Olivier Cussenot, Justine Varinot, J.A. Witjes, Marc-Olivier Bitker, Eva Compérat, Morgan Rouprêt, Pierre Conort, Solene-Florence Jacquet |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male medicine.medical_specialty Pathology Aetiology screening and detection [ONCOL 5] Kaplan-Meier Estimate Gastroenterology Quality of Care [ONCOL 4] Pathology and Forensic Medicine Molecular epidemiology [NCEBP 1] Lesion Translational research [ONCOL 3] Statistical significance Internal medicine Carcinoma Humans Medicine In patient Molecular Biology Aged Proportional Hazards Models Aged 80 and over Carcinoma Transitional Cell business.industry Proportional hazards model Large cell Carcinoma in situ Cell Biology General Medicine Middle Aged Prognosis medicine.disease Subtyping Urinary Bladder Neoplasms Disease Progression Female medicine.symptom business Carcinoma in Situ |
| Zdroj: | Virchows Archiv, 462, 343-8 Virchows Archiv, 462, 3, pp. 343-8 |
| ISSN: | 1432-2307 0945-6317 |
| Popis: | Item does not contain fulltext Urothelial carcinoma in situ (CIS) is a high-grade lesion with different subtypes (large cell pleomorphic (LCP), large cell nonpleomorphic (LC), small cell and clinging (CL)). We explored the frequency of different subtypes in primary CIS and compared different patterns with outcome. We explored whether subtyping of CIS leads to a change in therapy and/or follow-up and should be formally reported. We included 39 patients with a primary CIS and divided them into two groups: one with LPC/LG and one with CL elements. Other subtypes did not exist or occurred only as a mixture. Patient age ranged from 36 to 80 years (mean, 63 years). Twenty had a primary CIS with one single subtype. LCP was predominant with 16 (41 %) cases; the second most important subtype was the CL with four (10 %) cases. Mean follow-up was 26.4 months, (range, 4-100 months). Thirteen patients developed a >/= pT2 carcinoma. When progression of the different subtypes was examined, no statistical significance was found between mixed forms (p = 0.9437) nor between pure forms (p = 0.744 and p = 0.5955, respectively). Pathologists need not include different subtypes of primary CIS in their report as there is no difference in patient outcomes. It is important to recognize all different subtypes as CIS for best patient treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink